OPER SERIES OPEN TYPE PERMANENT-MAGNET MRI SYSTEM, MODEL: OPER-0.3, -0.35, -0.4

K092899 · Ningbo Xingaoyi Magnetism Co., Ltd. · LNH · Nov 10, 2009 · Radiology

Device Facts

Record IDK092899
Device NameOPER SERIES OPEN TYPE PERMANENT-MAGNET MRI SYSTEM, MODEL: OPER-0.3, -0.35, -0.4
ApplicantNingbo Xingaoyi Magnetism Co., Ltd.
Product CodeLNH · Radiology
Decision DateNov 10, 2009
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.1000
Device ClassClass 2
Attributes3rd-Party Reviewed

Intended Use

The OPER Series Open Type Permanent-Magnet MRI System is an open, whole body scanner. It is indicated for use as a diagnostic imaging device to produce transverse, sagittal, coronal and oblique images of the internal structures and organs of the head, body, or extremities. The images produced by the OPER Series Open Type Permanent-Magnet MRI System reflect the spatial distribution of protons (hydrogen nuclei) exhibiting magnetic resonance. The NMR properties that determine the image appearance are proton density, spin-lattice relaxation time (T1), spin-spin relaxation time (T2) and flow. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.

Device Story

Open, whole-body permanent-magnet MRI system (0.3T, 0.35T, 0.4T). Uses permanent magnets to align hydrogen nuclei; applies RF excitation pulses and magnetic field gradients (x, y, z) to encode spatial localization. Detects RF emissions (echoes) during proton relaxation. Console-based image reconstruction produces 2D/3D images (transverse, sagittal, coronal, oblique) based on proton density, T1, T2, and flow. Operated by trained professionals in clinical settings. Output viewed by physicians for diagnostic decision-making. Benefits include high-quality anatomical imaging without ionizing radiation.

Clinical Evidence

Bench testing only. Evaluated against NEMA performance standards (MS1-MS6, MS8) and IEC safety standards (60601-1, 60601-2-33). Metrics included signal-to-noise ratio, image uniformity, geometric distortion, slice profile/thickness/gap, and high-contrast spatial resolution.

Technological Characteristics

Permanent-magnet MRI system; 0.3T, 0.35T, 0.4T field strengths. Open architecture. Gradient subsystem for X, Y, Z field control. RF subsystem for signal transmission/reception. DICOM 3.0 compliant. Standards: IEC 60601-1, IEC 60601-2-33, IEC 60825-1, NEMA MS series.

Indications for Use

Indicated for diagnostic imaging of internal structures and organs of the head, body, or extremities in patients requiring MRI. Contraindications not specified.

Regulatory Classification

Identification

A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).

Special Controls

*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ | Document No. | | XGY/JW JS-20-003 | Page 8 of 25 | | |-----------------------------------------------------------------------------------------------------------------|----------|------------------|---------------------|------------| | Ningbo Xingaoyi Magnetism Co., Ltd. | Editor | Technical Dept. | Date | 2009-10-15 | | Response to FDA Reviewer Questions<br>Title OPER Series Open Type Permanent-Magnet<br>MRI System - Supplement 1 | Revision | A0 | Implementation Date | 2009-10-15 | # NOV 1.0 2009 # Appendix S1-2 Revised 510(k) Summary ### 1. 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 ad 21CFR 807.92. ## 2. General Information | Establishment: | | Ningbo Xingaoyi Magnetism Co., Ltd. | |---------------------------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------| | Address: | | East Tanjialing Road, South Area of Economic Development Zone,<br>Yuyao,Zhejiang, China, 315400 | | Phone: | | +86 574-62730899 - 8011 | | Fax: | | +86 574-62730908 | | Registration<br>Number: | | Xingaoyi will perform establishment registration and device listing before marking the device | | Contact Person: | | Jiang, Mowen<br>Technology Department Manager, Quality Representative<br>Phone:+86 574-62730899 -8011<br>E_Mail: Jiangmowen@163.com or Jiangmowen@gmail.com | | Date of Summary<br>Preparation: | | August 31, 2009 | | Device Name: | Trade Name: | OPER Series Open Type Permanent-Magnet MRI<br>System, Model: OPER-0.3, OPER-0.35, and OPER-0.4 | | | Classification Number: | CFR 892.1000 90-LNH | | | Classification: | Class II | {1}------------------------------------------------ K092899 Page 2/4 | Ningbo Xingaoyi Magnetism Co., Ltd. | Document<br>No. | XGY/JW JS-20-003 | Page 9 of 25 | | |-----------------------------------------------------------------------------------------------------------------|-----------------|--------------------|------------------------|------------| | | Editor | Technical<br>Dept. | Date | 2009-10-15 | | Response to FDA Reviewer Questions<br>Title OPER Series Open Type Permanent-Magnet<br>MRI System - Supplement 1 | Revision | A0 | Implementation<br>Date | 2009-10-15 | Applicable Standards: IEC60601-1: Medical electrical equipment-Part 1 General Requirement for safety IEC60601-2-33: Medical electrical equipment-Part 2-33 Particular requirement for the safety of magnetic resonance equipment for medical diagnosis. 21CFR subchapter J, Radiological Health IEC60825-1 Safety of laser products-Part 1: Equipment classification, requirement and user's guide. DICOM 3.0 PS 3.2 NEMA MS Series (MS1-MS6,MS8) ### 3. Safety and Effectiveness Information. #### 3.1 Device Description The OPER Series Open Type Permanent-Magnet MRI System (OPER MRI) is a series of open permanent magnet MRI system, with magnetic field strength of 0.3T, and 0.4T, respectively. The model number for each of the corresponding system is OPER-0.3, OPER-0.35, and OPER-0.4, respectively. The OPER MRI system utilizes a permanent magnet to acquire 2D single-slice and multislice and 3D volume images. A wide range of pulse sequences are provided to the operator, including spin echo, fast spin echo, 2D and 3D gradient echo acquisitions. Imaging options such as inversion recovery and flow compensation are provided to suppress artifacts due to physiological motion and improve image quality. #### 3.2 Scientific Concepts Magnetic Resonance (MR) is based on the fact that certain atomic nuclei have electromagnetic properties which cause them to act as small spinning bar magnets. The most ubiquitous of these nuclei is hydrogen, which makes it the primary nucleus used in current imaging experiments in MR. When placed in a magnetic field, there is a slight net orientation or alignment of these atomic nuclei with the magnetic field. The introduction of a short burst of radio frequency (RF) excitation of wavelength specific to the magnetic field strength and to the atomic nuclei under consideration can cause a reorientation of the proton's magnetization vector. When the RF excitation is removed, the proton relaxes and returns to its original orientation. The rate of relaxation is exponential, and varies with the character of the proton and its adjacent molecular environment. This reorientation process is characterized by exponential relaxation times called T1 and T2 which can be measured. {2}------------------------------------------------ K092899 page 3/4 | Image: Logo of Ningbo Xingaoyi Magnetism Co., Ltd.<br>Ningbo Xingaoyi Magnetism Co., Ltd. | Document No. | XGY/JW JS-20-003 | | Page 10 of 25 | | |-------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|------------------|------|---------------------|------------| | | Editor | Technical Dept. | Date | 2009-10-15 | | | Title | Response to FDA Reviewer Questions<br>OPER Series Open Type Permanent-Magnet<br>MRI System - Supplement 1 | Revision | A0 | Implementation Date | 2009-10-15 | These relaxation events are accompanied by an RF emission or echo which can be measured and used to develop a representation of these emission on a three dimensional matrix. Spatial localization is encoded into the echo by varying the RF excitation and by applying magnetic field gradients in x, y, and z directions, and changing the direction and strength of these gradients. Images depicting the spatial distribution of NMR characteristics of the nuclei under consideration can be constructed by using image processing techniques similar to those used in CT #### 3.3 Physical and Performance Characteristics MR is capable of producing high quality anatomical images without the associated risks of ionizing radiation. In addition, the biological properties that contribute to MR image contrast are different from those responsible for x-ray image contrast. In x-ray imaging, differences in x-ray attenuation, largely based on differences in electro density are responsible for the contrast observed in x-ray images. In MR imaging, differences in proton density, blood flow, and relaxation time T1 and T2 all may contribute to image contrast. In addition, by varying the pulse sequence characteristics, images may be produced in which the contrast is primarily dependent on T1 relaxation, proton density, or the molecular diffusion of water or other proton containing molecules. #### 3.4 Intended Use The OPER Series Open Type Permanent-Magnet MRI System is an open, whole body scanner. It is indicated for use as a diagnostic imaging device to produce transverse, sagittal, coronal and oblique images of the internal structures and organs of the head, body, or extremities. The images produced by the OPER Series Open Type Permanent-Magnet MRI System reflect the spatial distribution of protons (hydrogen nucle) exhibiting magnetic resonance. The NMR properties that determine the image appearance are proton density, spin-lattice relaxation time (T1), spin-spin relaxation time (T2) and flow. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. #### 3.5 Predicated Devices - Hitachi AIRIS II, manufactured by Hitachi Medical Systems America, Inc. K974212: - AIRIS II Version 4.1 Software, manufactured by Hitachi Medical Systems America, Inc. K001334: - Superopen 0.35T, Model NSM-P035 MRI System, manufactured by Neusoft Digital Medical K030918: Systems Co., Ltd. {3}------------------------------------------------ K092899 વ/વ | Image: Logo<br>Ningbo Xingaoyl Magnetism Co., Ltd. | Document<br>No. | | XGY/JW JS-20-003 | Page 11 of 25 | |-----------------------------------------------------------------------------------------------------------------|-----------------|--------------------|------------------------|---------------| | | Editor | Technical<br>Dept. | Date | 2009-10-15 | | Response to FDA Reviewer Questions<br>Title OPER Series Open Type Permanent-Magnet<br>MRI System - Supplement 1 | Revision | A0 | Implementation<br>Date | 2009-10-15 | #### 3.6 Statement of Substantial Equivalence The OPER Series Open Type Permanent-Magnet MRI System (OPER MRI) is of comparable type and substantially equivalent to Hitachi AIRIS II (K974212) and AIRIS II version 4.1 Software (K001334), and Neusoft NSM-P035 MRI System (K030918) in that they are similar in technology and intended uses. All three of these systems are open-permanent-magnet MRI Imaging System, use Gradient Subsystem to provide controlled and uniform gradient magnetic fields in the X, Y and Z directions, and use RF Subsystem to complete the function of RF signal transmitting/receiving and processing. Image reconstruction is controlled by console that has an interface, and the system produces 2D and 3D image that can be filmed or electronically stored for future review. All three of these systems have the traditional MRI units. #### 3.7 General Safety and Effectiveness Concerns Operation of the OPER Series Open Type Permanent-Magnet MRI System (OPER MRI) is substantially equivalent to the commercially available Hitachi AIRIS II and Neusoft NSM-P35. The following are the safety parameter with action levels: - Maximum Static Field - Rate of Change of Magnetic Field(dB/dt) - RF Power Deposition(SAR) . - Acoustic Noise Levels ● and performance levels: - . Specification Volume - Signal to Noise - . Image Uniformity - . Geometric Distortion - . Slice Profile, Thickness and Gap - High Contrast Spatial Resolution specified by the FDA guidance document for MR Diagnostic Devices that were evaluated. #### Summary of Results: The OPER Series Open Type Permanent-Magnet MRI System was evaluated to the appropriate NEMA performance standards as well as the IEC 60601-1 international medical equipment safety standards and the IEC 60601-2-33 Particular requirements for the safety of magnetic resonance equipment for medical diagnosis. The OPER Series Open Type Permanent-Magnet MRI System is substantially equivalent to its Predicate Devices in terms of safety and effectiveness. {4}------------------------------------------------ Image /page/4/Picture/0 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo features a stylized image of an eagle or bird with three curved lines forming its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the bird image. ### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002 Ningbo Xingaovi Magnetism Co., Ltd. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313 NOV 1 0 2009 Re: K092899 Trade/Device Name: OPER Series Open Type Permanent-Magnet MRI System Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device-Regulatory Class: II Product Code: LNH Dated: October 21, 2009 Received: October 22, 2009 Dear Mr. Job: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical {5}------------------------------------------------ Page 2 - Enclosure device-related adverse events) (21 CFR 803), good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Janine M. Morris Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health {6}------------------------------------------------ | Image: [logo]<br>Ningbo Xingaoyi Magnetism Co., Ltd. | Document<br>No. | XGY/JW JS-20-003 | | Page 7 of 25 | | |------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|--------------------|------|------------------------|------------| | | Editor | Technical<br>Dept. | Date | 2009-10-15 | | | Title | Response to FDA Reviewer Questions<br>OPER Series Open Type Permanent-Magnet<br>MRI System - Supplement 1 | Revision | A0 | Implementation<br>Date | 2009-10-15 | # Appendix S1-1 Revised Indications for Use Statement # Indications For Use 510(k) Number (if known): Device Name: OPER Series Open Type Permanent-Magnet MRI System Indications for Use: The OPER Series Open Type Permanent-Magnet MRI System is an open, whole body scanner. It is indicated for use as a diagnostic imaging device to produce transverse, sagittal, coronal and oblique images of the internal structures and organs of the head, body, or extremities. The images produced by the OPER Series Open Type Permanent-Magnet MRI System reflect the spatial distribution of protons (hydrogen nuclei) exhibiting magnetic resonance. The NMR properties that determine the image appearance are proton density, spin-lattice relaxation time (T1), spin-spin relaxation time (T2) and flow. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. CAUTION: Federal (US) law restricts the use of this device to licensed professionals. Prescription Use _ X _ (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) AND/OR Concurrence of CDRH, Office of Device Evaluation (ODE) Arny MWh Reproductive, Abdominal, and Radiological Dev 510(k) Number
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%